1. CARMEN M. WYNN
Carmen.Wynn@comcast.net
Mobile No. 773-556-9966
PUBLICATIONS
Erickson L, Wynn C, Pan F, Crews G, Xia G, Yamada T, Xu X, Tu Y, Huang D, Song
Y, Tamura K, Jiang H. Microarray gene expression profiling of chronic allograft
nephropathy in the rat kidney transplant model. Transpl Immunol. 2012
Oct; 27(2-3):75-82.
Cho KS, Yamada T, Wynn C, Behanna HA, Hong IC, Manaves V, Nakanishi T, Hirose
J, Abe Y, Jiang H, Tamura K, Saita Y. Mechanism analysis of long-term graft
survival by monocarboxylate transporter-1 inhibition. Transplantation. 2010 Dec
27; 90(12):1299-306.
Jang MS, Pan F, Erickson LM, Fisniku O, Crews G, Wynn C, Hong IC, Tamura K,
Kobayashi M, Jiang H. A blocking anti-CD28-specific antibody induces long-term
heart allograft survival by suppression of the PKC theta-JNK signal pathway.
Transplantation. 2008 Apr 15; 85(7):1051-5.
Fisniku O, Pan F, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K,
Kobayashi M, Benediktsson H, Jiang H. Protective effects of PG490-88 on chronic
allograft rejection by changing intragraft gene expression profiles. Transplant
Proc. 2005 May; 37(4):1962-4.
Crews GM, Erickson L, Pan F, Fisniku O, Jang MS, Wynn C, Benediktsson H,
Kobayashi M, Jiang H. Down-regulation of TGF-beta and VCAM-1 is associated with
successful treatment of chronic rejection in rats. Transplant Proc. 2005 May; 37(4):1926-8.
Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K,
Kobayashi M, Benediktsson H, Jiang H. PG490-88, a new immunosuppressant,
effectively prevents acute and chronic rejection in rat renal allografts.
Transplant Proc. 2005 Jan-Feb; 37(1):134-6.
Erickson L, Crews G, Pan F, Fisniku O, Jang MS, Wynn C, Kobayashi M, Jiang H.
Unique gene expression profiles of heart allograft rejection in the interferon
regulatory factor-1-deficient mouse. Transpl Immunol. 2004 Nov; 13(3):169-75.
Wynn C, Pan F, Erickson L, Ebbs A, Kobayashi M, Jiang H. High level of
TGF-beta in organ transplantation might be due to rejection rather than
calcineurin inhibitor medication. Transplant Proc. 2002 Aug; 34(5):1387-9.
Ebbs A, Pan F, Wynn C, Erickson L, Kobayashi M, Jiang H. Tacrolimus treats
ongoing allograft rejection by inhibiting interleukin-10 mediated functional
cytotoxic cell infiltration. Transplant Proc. 2002 Aug; 34(5):1378-81.
Jiang H, Wynn C, Pan F, Ebbs A, Erickson LM, Kobayashi M. Tacrolimus and
cyclosporine differ in their capacity to overcome ongoing allograft rejection as
a result of their differential abilities to inhibit interleukin-10 production.
Transplantation. 2002 Jun 15; 73(11):1808-17.
Jiang H, Yang XF, Wynn C, Soriano R, Krishnan K, Fujimura T, Kobayashi M.
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.
Transplant Proc. 2001 Feb-Mar; 33(1-2):510-3.